Form 4 Tracker
Avraham Gabay

Chief Financial Officer · 2 filings · Latest: Mar 17, 2026

ORAMED PHARMACEUTICALS INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ORMP
Gabay AvrahamJul 1, 2026
Proposed Sale
$4.8193,360$449.1K
ORMP
Avraham GabayChief Financial OfficerJan 22, 2026
Option Exercise
$0.0019,000649,256